Process Development Associate, Bioreactor Development
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a motivated Process Development Associate to join our Bioreactor and Scale-Up Development Group within Preclinical Manufacturing and Process Development (PMPD). In this role, you will work as part of the early-stage development team to develop production processes of biologics in a non-GMP process development laboratory, performing studies at pilot scale to develop clinically enabling manufacturing processes.
Job description
What you'll do
- Support lab operations to cultivate mammalian cells producing biologics in bench and pilot-scale bioreactors, including sterilizing, sanitizing, and operating bioreactors, preparing buffers and feeds, and maintaining and onboarding laboratory equipment
- Contribute to technology development projects to innovate process development and explore personal areas of interest
- Evaluate and solve challenges associated with the scale-up of processes
- Analyze seed train, production, and quality data to support process understanding and technology transfer, followed by authoring development reports, process transmittals, and documentation in electronic notebooks
- Participate in Technology Transfer Start-Up Teams by transferring technology via written reports and providing virtual and on-site support during clinical production campaigns
- Produce various non-clinical reagents to support Regeneron's Research and Development activities
The environment and physical rhythms of this role
- This is a non-GMP process development laboratory environment requiring the ability to work both independently and within a team environment on multiple projects simultaneously.
- Contribution to lab equipment maintenance and safety to help create a safe, effective, and efficient working environment is required.
Must-haves
- BS in Chemical Engineering or Bio-related Engineering with 0-3 years of experience in a laboratory setting
- Strong initiative and drive to complete bold tasks and learn new technologies
- Strong communication skills, including analytical, computer, and technical writing skills
Preferred / nice-to-haves
- Experience with NOVA FLEX, Sartorius Biostat DCU Bench Top Bioreactors, Biobrain Operate, Applikon bench top bioreactors, WAVE bioreactors, ABEC/Hyclone Single Use Bioreactors (50-500L), ABEC Stainless Steel Pilot Scale (40-500L) bioreactors, Medium Prep skid, CIP, Biosafety cabinets, incubators, autoclave, Perfusion Bioreactor, Continuous Processing, SynTQ, PI Historian, JMP, Benchling, and Ignition
Requirements
- BS in Chemical Engineering or Bio-related Engineering
- 0-3 years of experience in a laboratory setting
- Strong initiative and drive to complete bold tasks and learn new technologies
- Strong communication skills, including analytical, computer, and technical writing skills
Benefits
- Student Loan Paydown Program
- Tuition Reimbursement
- Family Care Benefits
- Relocation Assistance
- Inclusion, Culture and Well-Being Programs
- Annual Bonuses
- Equity Awards
- Pension or Retirement Benefits
- 401(k) Company Match
- Health and Wellness Programs
- Fitness Centers
- Insurance Benefits
- Paid Time Off
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.